TCT-707 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 3 Year Clinical Results

Ton Slagboom; Ralph Toelg; Bernhard Witzenbichler; Michael Haude; Monica Masotti; Rafael Jose Ruiz-Salmeron; Adam Witkowski; Ron Waksman; Shigeru Saito

首页> 外文期刊>Journal of the American College of Cardiology >TCT-707 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 3 Year Clinical Results

【24h】

TCT-707 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 3 Year Clinical Results

机译：TCT-707一种预期随机化多中心研究，评估orsiro西罗莫司的安全性和有效性在治疗中，在治疗中的受试者的治疗中的治疗，冠状动脉病变 - Bioflow IV：3年临床结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the American College of Cardiology》 |2018年第13期|共1页
作者
Ton Slagboom; Ralph Toelg; Bernhard Witzenbichler; Michael Haude; Monica Masotti; Rafael Jose Ruiz-Salmeron; Adam Witkowski; Ron Waksman; Shigeru Saito;
展开▼
作者单位

OLVG;

Herzzentrum Segeberger Kliniken;

Helios Amper-Klinikum;

Lukaskrankenhaus Neuss;

Hospital Clinic Barcelona;

Hospital Virgen Macarena. Sevilla;

Institute of Cardiology;

Medstar Washington Hospital Center;

Shonan Kamakura General Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. TCT-707 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 3 Year Clinical Results [J] . Ton Slagboom, Ralph Toelg, Bernhard Witzenbichler, Journal of the American College of Cardiology . 2018,第13期

机译：TCT-707一种预期随机化多中心研究，评估orsiro西罗莫司的安全性和有效性在治疗中，在治疗中的受试者的治疗中的治疗，冠状动脉病变 - Bioflow IV：3年临床结果
2. Five-year results of the multicenter randomized controlled open-label study of the CYPHER sirolimus-eluting stent in the treatment of diabetic patients with de novo native coronary artery lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients [J] . SinningJ.-M., BaumgartD., WernerN., The American heart journal . 2012,第3期

机译：CYPHER西罗莫司洗脱支架在多发性原发性冠状动脉病变糖尿病患者治疗中的多中心随机对照开放标签研究的五年结果：德国对西罗莫司洗脱支架有效性的多中心研究在糖尿病患者中
3. BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)-5 Year Clinical Results [J] . Slagboom Ton, Lefevre Thierry, Haude Michael, Journal of the American College of Cardiology . 2017,第18期

机译：Biotronik-Safety和临床表现的药物洗脱矿石支架在患有单德诺冠状动脉病变-II（Bioflow-II）-5年临床结果中的受试者
4. Clinical efficacy and safety of native bio-absorbable polymer Rapamycin-eluting stent (Excel stent) for Chinese patients with coronary artery disease [C] . Yanmin Xu, Guangping Li, Li Yin, International Congress on Coronary Artery Disease . 2009

机译：生物可吸收聚合物雷帕霉素洗脱支架（Excel支架）对冠心病患者的临床疗效和安全性
5. Preclinical and Clinical Evaluation of Biodegradable Polymer Coated Sirolimus Eluting Coronary Stents. [D] . Thakkar, Ashok S. 2011

机译：可生物降解的聚合物涂层西罗莫司洗脱冠状动脉支架的临床前和临床评估。
6. A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study [O] . Anna Franzone, Serge Zaugg, Raffaele Piccolo, -1

机译：一项比较XIENCE依维莫司洗脱支架与CYPHER西罗莫司洗脱支架治疗女性新发冠状动脉病变的随机多中心试验：SPIRIT WOMEN研究
7. TCT-606 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) – 2 Year Clinical Results [O] . Ruiz-Salmeron Rafael, Lefevre Thierry, Haude Michael, 2014

机译：TCT-606 BIOTRONIK-Orsiro药物洗脱支架治疗单发从头冠状动脉病变-II（BIOFLOW-II）的安全性和临床表现–两年的临床结果

TCT-707 A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects with up to two de novo Coronary Artery Lesions – BIOFLOW IV: 3 Year Clinical Results

著录项

相似文献

相关主题

期刊订阅